Skip to main content
High RiskFDAfda-F-0298-2013UNDECLARED ALLERGEN

Alden's Cookies and Cream is an ice cream product. It is packaged in a 1.5 quart (48 oz) cup. The LID of the recalled product is labe...

Category
Units Affected
1,400
Recall Date
September 20, 2012
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0298-2013.

Alden's Cookies and Cream was packaged in the wrong cup and a correct lid was used, but wheat was not declared on the finished product's label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0298-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Oregon Ice Cream, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0298-2013.

Oregon Ice Cream, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Oregon Ice Cream, Llc Recall FAQ

Oregon Ice Cream, Llc is the subject of a dairy safety report: Alden's Cookies and Cream is an ice cream product. It is packaged in a 1.5 quart (48 oz) cup. The LID of the recalled product is labe.... The notice was published on September 20, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 1,400 units are potentially affected.